Biomedical application of human pluripotent stem cell-derived hepatocyte-like cells (hPSC-HLCs) relies on efficient large-scale differentiation, which is commonly performed by a suspension culture of threedimensional (3D) multicellular spheroids in bioreactors. However, this approach requires large amounts of growth factors (GFs) and the need to overcome limited diffusional transport posed by the inherent 3D structure of hPSC spheroids. Here, we have hypothesized that localized delivery of GFs by incorporation of GF-laden degradable polymeric microparticles (MPs) within the hPSC spheroids would circumvent such limitations. In this study, GFs for hepatocytic differentiation were encapsulated in gelatin-coated poly (L-lactic acid)/poly (DL-lactic-co-glycolic acid) (PLLA/PLGA) MPs which were subsequently incorporated into the hPSC spheroids. Gene expression analyses demonstrated that MP delivery of the GFs resulted in similar expression levels of hepatocytic markers despite the use of 10-fold less total GFs. The differentiated HLCs in the MP group exhibited ultrastructure and functional characteristics comparable with the conventional soluble GF group. The generated HLCs in the MP group were successfully engrafted in an acute liver injury mouse model and maintained hepatocytic function after implantation. These results suggested that sustained and localized delivery of GFs using MPs might offer a novel approach towards scalable technologies for hepatocytic differentiation and engineer a better 3D microenvironment for cells.
Introduction
Human pluripotent stem cell-derived hepatocyte-like cells (hPSC-HLCs) provide a potential supply for hepatic tissue engineering, drug screening, and cell-based therapies [1] . Thus, a scalable, efficient and cost-effective protocol that differentiates hPSCs into hepatocytes in a bioreactor is a crucial step toward their biomedical applications. In recent years, three-dimensional (3D) cell cultures (spheroids) have been used for expansion of hPSCs [2] and hepatocytic differentiation of hPSCs [3, 4] , successful engraftment of the transplanted hPSC-HLCs [5] , and maintenance of hepatocytes [6, 7] . Spheroid cultures in suspension provide a 3D environment with efficient cell-cell contacts [8] . However, there are two pivotal challenges for scalable hepatocytic differentiation of hPSCs. First, consecutive renewal of soluble growth factors (GFs) is necessary in the conventional approach in 3D differentiation of hPSCs. This is costly because of the high consumption of GFs.
Second, these 3D spheroids have size limitations due to insufficient diffusion of soluble GFs into the spheroids [9, 10] . The outer layer of spheroids is exposed to higher concentrations of soluble GFs, whereas cells in the core part receive lower amounts. According to Fick's law of diffusion, inner regions are exposed to lower levels of GFs because this requires more time to reach the central regions of the spheroids [10] . Furthermore, the dense shell on the surface and marginal zone that contains collagen I, tight cellecell junctions, and a basement membrane have been shown to hinder diffusion based transport from the outside [9, 11] . The microenvironment within cell spheroids varies by location because of cellecell interactions, diffusional constraints, and secretion of matrix and paracrine factors [11] .
One approach to overcome these problems in 3D differentiation of hPSCs could be the incorporation of microparticles (MPs) within the hPSC spheroids for sustained release and homogenous distribution of morphogens throughout the spheroids (for review see Refs. [12, 13] ). Morphogen-loaded biodegradable MPs are widely used as inside-out delivery vehicles in differentiation of multicellular spheroids of mesenchymal stem cells, neural stem cells, and embryonic stem cells (ESCs) into germ cells [14] , mesoderm and ectoderm lineage derivatives [15] , primitive streak cells [16] , blood cells [17] , osteogenic or angiogenic cells [18, 19] , chondrocytes [20] , tendon cells [21] and mature neurons [22] . The ability to localize morphogens within spheroids by MP-mediated delivery has been used for spatiotemporal control of differentiation within 3D cultures. However, to the best of our knowledge, there is no report about the application of GF controlled release by MPs for efficient directed differentiation of hPSCs to hepatocytes in a suspension culture.
We have hypothesized that the incorporation of GF-laden degradable polymeric MPs within human embryonic stem cell (hESC) spheroids would circumvent such limitations in the 3D suspension culture and result in efficient hepatocytic differentiation. To address this hypothesis, we first documented the characteristics of poly (L-lactic acid)/poly (DL-lactic-co-glycolic acid) (PLGA/PLLA) MPs loaded with two key GFs for hepatocytic differentiation [hepatocyte growth factor (HGF) and fibroblast growth factor 4 (FGF4)]. Then, we aggregated hESCs with GF-loaded MPs within the 3D culture suspension and differentiated them into a hepatocytic fate. We reduced the total consumption of GFs to onetenth by MP delivery to have a cost-efficient application of GFs in large-scale differentiation in a bioreactor. Compared to the conventional soluble delivery method, gene expression analyses demonstrated that incorporation of GF-loaded MPs resulted in similar expression levels of hepatocytic markers, ultrastructure, and functional characteristics. These results suggested that MP delivery of GFs with less consumption might offer a novel approach towards overcoming the current limitations associated with scalable suspension technologies of 3D hPSC spheroids and engineer a more efficient 3D microenvironment for biomedical applications of hPSCs.
Materials and methods

Fabrication of microparticles (MPs)
We used PLGA (50:50, Resomer ® RG 504 H, Sigma-Aldrich) to fabricate the microspheres according to the water-in-oil-in-water double emulsion solvent extraction technique. We prepared two separate solutions of 40 mg PLLA/PLGA (1:1) in 2.5 ml dichloromethane (DCM), and 4.5 mg each of HGF and FGF4 in 0.6 ml phosphate-buffered saline (PBS) supplemented with GF stabilizers [heparin and bovine serum albumin (BSA, Sigma-Aldrich, A3311)]. Next, the polymer organic solution and GF aqueous solution were mixed and emulsified by homogenization at 6000 rpm for 2 min. The prepared single emulsion was immediately emulsified in 200 ml of dH 2 O that contained 0.1% w/v methylcellulose and 1% w/ v PVA by a mechanical stirrer at 400 rpm to produce a water-in-oilin-water double emulsion. The methylcellulose solution used in this emulsification step was partially saturated by the addition of 1.8 ml DCM to prolong the extraction of DCM from the oil droplets by water and prevent premature hardening of the microspheres before the two polymers could phase separate. Controlled extraction of DCM and hardening of the polymer droplets were initiated after 30 min by the addition of another 200 mL of a 0.1% w/v methylcellulose solution without DCM. This extraction was performed with a peristaltic pump at a rate of 1 mL/min and stirring at room temperature (RT). The resultant hardened microspheres were filtered, washed with water, and freeze-dried overnight. Blank MPs were produced similarly, except we did not use GF in the first water phase. A total of 10 mg of CellTracker Red (CTR; Biotechnology; C34552) was dissolved into DCM prior to preparation of the emulsion to produce fluorescent-labeled MPs to track the MPs in spheroids. The prepared MPs were morphologically analyzed by scanning electron microscopy (SEM, VEGA\TESCAN) and the particle size distribution was determined by dynamic light scattering (DLS, Mastersizer 2000, Malvern).
Growth factor (GF) release from microparticles (MPs)
We investigated GF release profiles from the MPs by suspending 5 mg of gelatin-coated MPs into 0.5 mL of PBS supplemented with 0.02% Tween 20 and 10 mg/ml BSA. The MPs were incubated at 37 C. The samples were centrifuged and the entire supernatant collected at specific time points over a period of 20 days. Next, we added fresh release medium. The supernatants were stored at À20 C until the HGF and FGF4 contents were quantified by enzyme-linked immunosorbent kits (ELISA; R&D Systems). Concentrations of GFs were determined by comparison to standard curves. All analyses were conducted in duplicate.
To determine encapsulation efficiency, 5 mg of the GF-loaded microspheres was dissolved in 1 ml NaOH (1 N), which contained 1% SDS by stirring for 24 h at RT. Then, the clear solution was centrifuged for 5 min at 5000 rpm. The supernatant was analyzed by a BCA kit (Pierce BCA Protein Assay Kit; Thermo Fisher Scientific) to measure the total protein content. The loading efficiency was calculated using (m2/m1x100) where m2 was the measured weight of protein in MPs and m1 was the total weight of protein used for MP fabrication.
Three-dimensional (3D) cell spheroid formation
We used the RH5 hESC line [23] . A total of 3 Â 10 5 live cells/mL were transferred to low attachment bacterial plates (60 mm; Griner, 628102) with 5 mL of hESC medium and conditioned for 24 h on inactivated human foreskin fibroblasts (HFFs) with mitomycin C (Sigma-Aldrich; M0503) [2, 24] . hESC medium included Dulbecco's modified Eagle's medium (DMEM/F12; Gibco, 21331e020), 20% knockout serum replacement (KOSR; Gibco, 10828e028), 0.1 mM b-mercaptoethanol (Sigma-Aldrich; M7522), 1% penicillin and streptomycin (Gibco; 15070e063), 1 mM nonessential amino acids (Gibco; 11140e035), 2 mM L-glutamine (Gibco; 25030e024), 1% insulinetransferrineselenium (ITS; Gibco, 41400e045), and 100 ng/mL bFGF (Royan Biotech). For MP incorporation, the UV-sterilized PLGA MPs were coated with gelatin via a sonication-mediated suspension in a sterile gelatin solution (0.1% w/v) and incubated for 3 h at RT with mild stirring, followed by centrifugation. We subsequently removed the supernatant and washed the MPs twice with PBS. The gelatin-coated MPs were re-suspended in culture medium. We used a hemocytometer to determine particle density. Finally, we mixed the desired volumes of the MP and hESC suspensions to obtain a cell to MP ratio of 3:1. The plates were incubated under standard conditions (37 C, 5% CO 2 , and saturated humidity). After 24 h, the single cells successfully aggregated.
Hepatocytic differentiation procedure
After spheroid formation, we changed the media of the plates to differentiation medium. Fig. 2A shows the stepwise differentiation protocol of hESCs to HLCs. There were three stages: definitive endoderm formation (DE, 3 days), hepatoblast (HB, 7 days), and hepatocyte-like cell (HLC, 10 days). During DE formation the medium consisted of RPMI 1640 (Invitrogen; 51800), 0.1% BSA, and 1% B27 (Gibco; 12587e010). The medium was supplemented with 6 mM CHIR99021 (Stemgent; 04-0004-10) for one day followed by 10 ng/ml activin A (R&D Systems; 338-AC) for two days. In the HB stage, the base medium DMEM-F12 was supplemented with 2% KOSR, 10 ng/ml HGF (R&D Systems, 294-HG), and 10 ng/ml FGF4 (Royan Biotech) for 7 days. Then, the cells were treated for an additional 10 days in a 1:1 ratio of hepatocyte basal medium (HBM; Lonza, CC-3199) and DMEM/F12 that contained 2% KOSR, 10 ng/mL oncostatin M (OSM; R&D Systems, 295-OM), 0.1 mM dexamethasone (Dex; Sigma-Aldrich, D-2915), 1 mM nonessential amino acids, and L-glutamine. The hepatocytic differentiation protocols were the same for both soluble GF delivery [S (1X)] and MPmediated GF delivery [MP (0.1X)] groups, except that the later received HGF and FGF4 via MP-delivery instead of the soluble form.
Gene expression assay
We used quantitative real-time reverse transcriptase polymerase chain reaction (qRT-PCR) to verify the cell expression profile during differentiation. Total RNA was extracted with TRIzol (SigmaAldrich, T9424), then treated with an RNase-free DNase (Takara, 2270A1) to eliminate cDNA. Next, cDNA was generated with a RevertAid First Strand cDNA Synthesis Kit (Takara kit) based on the manufacturer's instructions. Duplicate qRT-PCR reactions were performed with the SYBR Green Master Mix (Takara Bio, Inc., SYBR Premix Ex Taq II RR081Q) by the real-time PCR system (Corbett Life Science; Rotor-Gene 6000 instrument) and analyzed with RotorGene 6000 analysis software (Corbett Life Science; version 1.7). The samples were collected from three independent biological replicates. The expression levels of the desired genes were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the reference gene and then normalized to corresponding stem cells. The expression profile of differentiated cells in different groups was compared to a hepatocytic cell line, Huh7 as the positive control. Analysis was performed by the comparative CT method (2 ÀDDCt ). Primers are listed in Supplementary Table S1 .
Immunofluorescence assay
Spheroids of HLCs were collected at the end of day 20. The spheroids were washed with PBS and fixed overnight at 4 C with 4% (w/v) paraformaldehyde (Sigma-Aldrich, P6148). Then, spheroids were embedded in agar gel and subsequently embedded in paraffin blocks. The 6 mm sections were prepared and deparaffinized. Next, sections were treated with antigen retrieval (Dako) and then permeabilized by using 0.1% Triton X-100 for 10 min. For blocking, we used 10% goat serum (SAFC Bioscience, 12306 C) in PBS for 1 h at 37 C. The slides were incubated overnight with primary antibodies at 4 C. Finally, the sections were washed 4 times and incubated with secondary antibodies for 1 h at 37 C. Nuclei were counter-stained with 0.5 mg/ml of 4 0 ,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, D8417) for 1 min. The immunofluorescent micrographs were taken with a fluorescent microscope (BX51; Olympus, CP70 camera). For the negative control, we applied the same staining procedure without primary antibodies. Supplementary Table S2 summarizes the list of antibodies.
Flow cytometry analysis
Differentiated cells in hepatocytic-like spheroids were dissociated by trypsin, fixed in 4% paraformaldehyde for 20 min at RT, permeabilized in 0.1% Triton X-100 for 10 min at RT, and blocked in 10% secondary antibody host serum in 0.5% BSA for 1 h at RT. Next, HLCs were incubated overnight with primary antibodies at 4 C. Primary and secondary antibodies were the same as those used for immunofluorescence staining. Flow analysis was performed using a BD-FACS Calibur flow cytometer (FACSCalibur). Analyses were performed on three independent biological experiments. Data were analyzed using the Flowing software (version 2.5.1, Turku Centre for Biotechnology).
Cytochrome P (CYP) activity and inducibility
We have used the ethoxyresorufin-O-deethylase (EROD) and pentoxyresorufin O-dealkylase (PROD) assays to evaluate CYP450 enzyme activity. Ethoxyresorufin and pentoxyresorufin are nonfluorescent substrates which are O-deethylated and O-dealkylated by the CYP450 system (CYP2B1/2 and CYP1A1, respectively) and converted into resorufin, a red fluorescent substance. Hepatocytic-like spheroids were incubated with 2 mM phenobarbital (PB) for 3 days. Next, the spheroids were washed and transferred into medium that contained 5 mM 7-ethoxyresorufin (Sigma-Aldrich; E3763) or 7-pentoxyresorufin (Sigma-Aldrich; P9049) and 80 mM dicumarol (Sigma-Aldrich; M1390) in Hank's balanced salt solution. The plates were incubated at 37 C for 30 min. The supernatant from the spheroids was collected for a fluorescent intensity assay using a BioTek plate reader (BioTek Synergy™ 4).
Indocyanine green (ICG) uptake assay
Differentiated hepatocytic-like spheroids were incubated with indocyanine green (ICG, 1 mg/ml; Sigma-Aldrich, 12633) for 1 h at 37 C according to the manufacturer's instructions. Uptake of ICG was visualized with a light microscope.
Low-density lipoprotein (LDL) uptake assay
Low-density lipoprotein (LDL) uptake assay was performed using DiI-Ac-LDL (Biomedical Technologies, Inc., BT-902) according to the manufacturer's instructions. Fluorescent images were captured by a fluorescent microscope (IX71, Olympus).
Periodic acid-Schiff (PAS) staining
We evaluated the capacity of differentiated hepatocytic-like spheroids to store glycogen. Hepatocytic-like spheroids at day 20 were evaluated by the periodic acid-Schiff (PAS) method. Briefly, the spheroid sections were oxidized in 1% periodic acid for 5 min and rinsed in dH 2 O. Sections were subsequently treated with Schiff's reagent for 15 min following color development in dH 2 O for 5e10 min.
Albumin (ALB) and urea production assays
After 48 h incubation, conditioned media from differentiated hepatocytic-like spheroids were collected and stored at À20 C. The amount of ALB secreted into the culture media was quantified using a human ALB ELISA kit (Bethyl, E80-129) according to the manufacturer's instructions with a microplate reader (Thermo Scientific, Multiskan Spectrum, 51118650). The amount of urea produced was determined by a colorimetric assay kit (Biorexfars, BXC0126A, 941210) according to the manufacturer's instructions. The results were normalized to total protein (Total Protein Kit, Biorex, BXC0173A, 921239) according to the manufacturer's instructions. All tests were carried out in three biological replicates. The data from ALB secretion and urea production of primary human hepatocytes were used as positive controls in this study.
Transmission electron microscopy (TEM)
We observed the ultrastructure of the hepatocytic-like spheroids by transmission electron microscopy (TEM). Spheroids were washed twice with PBS, pre-fixed with 2.5% glutaraldehyde in 0.1 M PBS (pH 7.4) for 2 h, and then post-fixed with 1% osmium tetroxide for 1.5 h. The spheroids were dehydrated in a graded acetone series and embedded in epoxy resin (TAAB, UK). Then, 60e70 nm (silvergrade) sections were prepared by an ultra-microtome (Leica Ultra Cut UC6, Austria). The sections were double-stained with 5% uranyl acetate and 0.5% lead citrate, then visualized using a Zeiss EM 900 transmission electron microscope (Germany) with an accelerating voltage of 50 kV.
Cell transplantation in an animal model
Acute liver injury was induced in 10-week old male NMRI mice by an intraperitoneal injection of 0.6 ml/kg of CCl4 (Sigma-Aldrich). We used four animal groups for the in vivo experiment: healthy mice (normal), acute liver injury model (control), and acute liver injury model with transplanted HLCs differentiated by S (1X) or MP (0.1X) treatments. Hepatocytic-like spheroids were enzymatically dissociated into single cells and labeled with PKH26 (Red Fluorescent Cell Linker Kit, Sigma-Aldrich; P9691) according to the manufacturer's instructions. The S (1X) and MP (0.1X) transplanted groups received intrasplenic injections of 1 Â 10 6 cells 24 h after induction of acute liver injury. The transplanted animals were immunosuppressed with daily cyclosporine (Novartis Pharmaceuticals, 20 mg/kg) 4 days before cell transplantation until one week after transplantation. The normal group in this study received immunosuppression, whereas the control group received immunosuppression and CCL4 injection. After one week, the blood samples were collected and the levels of alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase (ALP), and total bilirubin were measured by commercially available kits (Biorexfars, BXC0215A, BXC0205A, BXC0185A, BXC0191A). Human ALB (hALB) was quantified by the hALB ELISA Kit (Bethyl; E80-129). Liver samples were collected for histologic analysis to track the engrafted cells. The liver samples were fixed in 10% formalin and enblocked in paraffin. Then, the nuclei in the liver tissues of the 6 mm sections were counterstained with DAPI (Sigma; D8417 
Statistical analysis
Data are presented as mean ± standard deviation (SD) from at least three biological replicates. Comparisons were made with the student's t-test or one way-analysis of variance (ANOVA), followed by Tukey's post-test. P-values less than 0.05 were considered significant. , and HLC maturation (10 days). The hepatocytic differentiation protocol was the same for both the S (1X) and MP (0.1X) groups, except that the latter received hepatocyte growth factor (HGF) and fibroblast growth factor 4 (FGF4) via MP-delivery instead of the soluble form. Total GF consumption was 400 ng for each HGF and FGF4 per replicate in the conventional soluble method (10 ng/ml x 8 times medium renewal x 5 ml medium per renewal), whereas it was 40 ng for each GF in the MP delivery method. We used 5 ml medium per plate. Based on the measured GF of 56 ng GF/mg MP and the particle density of 5 Â , (F) LGR5, and (G) OCT4 on day 20 of differentiation. The nuclei were counterstained with DAPI. Scale bar: 50 mm.
Results
Production and characterization of microparticles (MPs)
PLGA is a biocompatible and biodegradable polymer commonly used for MP-mediated delivery of GFs. Biodegradability of PLGA is governed by hydrolyzation into lactic acid and glycolic acid which are natural by-product metabolites [25] . Although GF release from PLGA microspheres can be controlled by creating variations in the polymer properties of molecular weight, copolymer ratio and crystallinity, it usually suffers from an initial burst release [25, 26] . In this study, we have used a modified double emulsion method to produce PLGA/PLLA MPs with minimal burst release (Fig. 1A) . MP incorporation within the spheroids was the first validated challenge step prior to the differentiation steps. Cell-MP interaction is necessary for efficient incorporation [27] . Therefore, we coated the surface of MPs with a thin layer of gelatin before mixing them with single hESCs (Fig. 1A) . Analysis of protein loading showed that approximately 50% of the GFs loaded within the MPs. Fig. 1B shows the release profiles of HGF and FGF4 from MPs over 20 days. MPs were labeled with CTR for tracking after incorporation within the cell spheroids (Fig. 1C) . According to DLS analysis, the MPs had a mean diameter of 2.01 ± 0.97 mm (Fig. 1D and E).
Initially we examined various cell to MP ratios. We observed an efficient spheroid formation at a 3:1 cell to MP ratio in hESC medium. After 24 h, the MPs successfully incorporated within the cell spheroids ( Fig. 2A) . This ratio was selected to avoid the effects of differentiation by the MPs [15] . Immunofluorescent microscopy showed homogenous distribution of the CTR-labeled MPs throughout the hESC spheroids (Fig. 2B) . Repeatedly, by using approximately 2 mg of lyophilized MPs, we measured the particle number as 10 6 particles, which was considered the base for calculating the required amount of MPs. Fig. 2A shows the stepwise differentiation protocol of hESCs to HLCs that included three steps: DE (3 days), HB (7 days) and HLC maturation (HLC, 10 days). The hepatocytic differentiation protocol was the same for both the S (1X) and MP (0.1X) groups, except that the latter received HGF and FGF4 via MP-delivery instead of the soluble form. Total GF consumption was 400 ng/10 6 cells for each HGF and FGF4 ( Fig. 2A) .
Based on the measured GF content of 56 ng GF/mg MP and particle density of 5 Â 10 5 particles/mg MP, we obtained a one-tenth consumption of GFs by using the 3:1 cell to MP ratio.
Characterization of hepatocyte-like cell (HLC) differentiation via microparticle (MP) delivery of growth factors (GFs) in spheroids 3.2.1. Morphological and gene expression analyses
After 20 days of differentiation, we observed no significant differences between the S (1X) and MP (0.1X) groups in cell spheroid morphology as demonstrated by phase contrast microscopy and hematoxylin and eosin (H&E) stained cross-sections (Fig. 3A) . Both groups contained cystic and dense spheroids. However, the majority were dense spheroids (75%). We also analyzed mRNA expressions of the pluripotency marker, OCT4, and hepatocytespecific genes a-fetoprotein (AFP), ALB, hepatocyte nuclear factor 4a (HNF4a), tyrosine aminotransferase (TAT), transthyretin (TTR), Ecadherin (CDH1), asialoglycoprotein receptor (ASGPR), glucose-6-phosphatase (G6PC), and cytochrome P450 subunits 3A7 (CYP3A7) and 3A4 (CYP3A4) by qRT-PCR (Fig. 3B) . We observed significant downregulation of OCT4 during differentiation in the presence of GF in both the S and MP groups (Fig. 3B) . MP-mediated delivery of HGF and FGF4 resulted in similar upregulation of the hepatocytic specific genes with no significant differences with the soluble group (Fig. 3B) . The use of 10-fold less GFs in conventional soluble delivery without MPs [S (0.1X)] significantly decreased expressions of the hepatocytic genes compared to S (1X) and MP (0.1X) groups (at least P < .05, Fig. 3B ). The presence of unloaded MPs within the cell spheroids without HGF and FGF4 in the culture medium [MP (0)] significantly decreased expressions of the hepatocytic genes compared to the S (1X) and MP (0.1X) groups (at least P < .05, Fig. 3B ). These results suggested that, compared to treatment with S (1X), MP (0.1X) delivery of HGF and FGF4 within hESC spheroids resulted in similar expressions of hepatocyte-specific genes.
Immunofluorescence staining on day 20 showed that the cells in both the S (1X) and MP (0.1X) groups expressed hepatocytic markers, AFP (Fig. 4A), ALB (Fig. 4B ), E-cadherin (Fig. 4C) , CYP3A4 (Fig. 4D), CYP7A1 (Fig. 4E), and LGR5 (Fig. 4F) . However, the pluripotency marker OCT4 was not detectable in HLCs in both groups (Fig. 4G) .
In addition, flow cytometry analysis was performed on day 20. Spheroids treated in S (1X) and MP (0.1X) groups showed no significant difference for expressions of AFP and ALB. Approximately 50% of cells expressed these markers in both groups (Fig. 5) .
Ultrastructural analysis of differentiated cells demonstrated a considerable difference in the S (1X) and MP (0.1X) groups when compared with hPSCs [28] . We observed some similarities to immature hepatocytes (Fig. 6) [29, 30] . TEM analysis showed microvilli (MV) at the apical side of the differentiated cells with abundant cellecell contacts that consisted of tight junctions (TJ). There were other intercellular junctions, especially the gap junction (GJ) and fascia adherence (FA), observed between adjacent cells. Bile-like canaliculi (BLC) were occasionally observed between adjacent cells covered with MV. The differentiated HLCs contained large euchromatic nuclei (N), numerous mitochondria (M), developing Golgi apparatus (Go), rough and smooth endoplasmic reticuli (rES and sER), lysosome (Ly) and lipid droplets (L), and glycogen granules (G) in their cytoplasm.
Functional analysis
We assessed the activities of CYP2B1/2 and CYP1A1 according to ethoxyresorufin-O-deethylase (EROD) and 7-pentoxyresorufin-O dealkylase (PROD) levels, respectively. In addition, the inducible hepatocytic CYP-mediated PROD and EROD activities were demonstrated before and after PB induction. We used fluorescence microscopy and related software to evaluate these results (Fig. 7A) .
In both groups, the fluorescence intensity of the supernatant medium increased significantly after 3 days of induction with PB; however, there were no significant differences in the S (1X) and MP (0.1X) groups (Fig. 7B) . HLCs in both groups showed uptake of ICG (Fig. 7C) and DiI-Ac-LDL (Fig. 7D) . PAS staining showed glycogen storage in both groups (Fig. 7E) . We assessed the cells for their ability to produce ALB and urea in culture. The results indicated that both groups produced similar levels of ALB (Fig. 7F) and urea (Fig. 7G) . The ALB secretion and urea production of primary human hepatocytes were used as positive controls (Fig. 7F and G) . As expected, the primary hepatocytes remarkably showed better physiologic function according to higher ALB secretion and urea production.
In order to assess whether the differentiated cells were engraftable, we transplanted 1 Â 10 6 PKH-labeled HLCs into the spleens of cyclosporine-treated mice with acute liver damage after CCl4 treatment. After one week, we detected PKH-labeled HLCs in the livers of the transplanted animals by fluorescent microscopy. Most engrafted cells were detected near the pericentral zones. Double PKH/hALB positive cells were considered to be functionally transplanted HLCs (Fig. 8A) . PKH-positive cells comprised approximately 2% within the recipient livers in both the soluble and MP groups (Fig. 8C) . We noted that 80% of PKH positive cells were hALB positive in both groups. We also confirmed the presence of unlabeled human cells by immunofluorescence staining for human anti-mitochondria (Fig. 8B-i and ii) and the function by expression of CYP3A4 (Fig. 8B-iii) . We measured hALB in the mice sera to explore the functionality of these PKH-positive transplanted cells. We detected 47.6 ± 20.3 ng/mL [S (1X) group] and 52.8 ± 26.8 ng/ mL [MP (0.1X) group] hALB in the sera of these mice (Fig. 8D) . Finally, we measured changes in liver enzymes (ALT, AST, and ALP) and total bilirubin levels. The cell transplanted groups, S (1X) and MP (0.1X), were compared with the control (CCl4) group. There were significant decreases in the plasma levels of ALT (Fig. 8E) and AST (Fig. 8F ) in animals treated with HLCs from both the S (1X) and MP (0.1X) groups compared with the control group. ALP plasma levels (Fig. 8G ) and total bilirubin (Fig. 8H ) decreased in the celltransplanted groups. These decreases were not significant in both groups when compared to control group.
Discussion
A cost-effective, efficient protocol for scalable production of human desired cells such as hepatocytes from hPSCs is highly dependent on spatially and temporally controlled presentation of morphogenic factors. In this study, we have demonstrated that localized delivery of GFs by PLGA/PLLA MPs could be used as an efficient, cost-effective alternative to their soluble supplementation for scalable hepatocytic differentiation of hESCs in a 3D suspension culture. Compared to the conventional soluble delivery method, gene expression analyses showed that MP delivery of GFs resulted in similar expression levels of hepatocytic markers ALB, AFP, CYP3A4, CYP3A7, HNF4a, E-cadherin, G6PC, TAT, TTR, and ASGPR as well as at the protein level, despite the use of 10-fold less total GFs. Differentiated HLCs in the MP group showed ultrastructure and functional characteristics of glycogen storage, ICG uptake, ALB secretion, urea production, LDL uptake, and inducible cytochrome P450 activity comparable to the soluble GF group. HLCs in the MP group demonstrated successful engraftment into the liver and continued to present hepatocytic function as shown by ALB secretion after implantation and improvement in liver enzymes. These findings were comparable to the soluble GF group. In contrast, one-tenth of GFs in the soluble group, S (0.1X) or GF-free MPs, and MP (0) in spheroids did not lead to efficient hepatocytic differentiation.
These results agreed with other reports that demonstrated efficient differentiation of stem cell spheroids by MP delivery of various morphogens such as transforming growth factor-beta1 (TGF-b1) for chondrogenic differentiation of human MSC spheroids [20] , nerve growth factor (NGF) for neural differentiation of mouse neural stem cell spheroids [22] , bone morphogenic protein 4 (BMP4) to generate meiosis-competent germ cells from mouse ESCs [14] , and retinoic acid to produce primitive streak cells from mouse ESC spheroids [16] . Qutachi et al. reported that MP delivery of multiple factors -simvastatin, BMP2, and VEGF within hESC aggregates facilitated localized osteogenic and vasculogenic differentiation [18] . Some studies reported that MP delivery within cell spheroids resulted in decreased consumption of GFs compared to the conventional soluble delivery method. For instance, MP delivery of BMP4 or noggin within mouse ESC spheroids induced efficient gene expression of mesoderm and ectoderm lineages, respectively despite the use of 12-fold fewer total GF [15] . Similarly, BMP4 and thrombopoietin delivery inside the mouse ESC spheroids resulted in efficient blood cell differentiation while GF consumption was reduced~14.2-fold [17] .
Interestingly, GF-loaded MPs resulted in less cystic spheroids at the final step of differentiation with mostly dense spheroids (Fig. 3A) . In our previous study, we reported that cystic spheroids of hPSC-HLCs expressed mesoendodermal markers (BRA, FAXA2, SOX17) more than dense spheroids, whereas early and late hepatocytic markers (HNF4a, AFP, ALB, TAT, CDH1, ASGPR1) demonstrated higher upregulation in the dense spheroids [3] .
The cells located in the marginal layers had better opportunity to exchange the necessary biomolecules with culture medium. The cells located in the core of the aggregates depended on simple diffusion to exchange crucial nutrients and biomolecules. This might be the reason for better demonstration of hepatocytic characteristics in the marginal layers.
As proof of concept, we demonstrated that HLCs generated from MP delivery of dual hepatogenic factors within hPSC spheroids transplanted intrasplenic into an acute liver injury model as single cells successfully engrafted within the liver tissue and continued to secret ALB. Notably, some reports suggested that localized and sustained delivery of HGF within cell encapsulated hydrogels would result in higher engraftment and maintenance of the HLCs in vivo [31, 32] . However, transplantation of hepatocytes as multicellular spheroids is preferable for efficient engraftment and prolonged function in vivo [33] . Both requirements have been met in our developed GF-MP incorporated HLC spheroids. These composite spheroids can be considered as scaffold-free micro-tissues with endogenous sustained release of HGF, which can be transplanted as prepared and are highly expected to show great potential for in vivo engraftment and hepatocytic function. This approach is not possible by the use of recently developed FGF1 and HGF-releasing nanoparticles, which are solely applicable to single cells and require a scaffold for in vivo co-delivery of the cells and GFs [34] . Fabrication of MPs from biomaterials with engineered affinity to GFs, which are exogenously loaded in MPs or endogenously released from the cells during differentiation, may present an opportunity to sequester and harness signaling within 3D spheroids for more efficient differentiation [15] . Such an approach can target different GFs according to the differentiation method and desired cells.
In order to generate the MP-incorporated cell spheroids, we used the static liquid overlay where cultured dispersed hESCs in a nonadherent bacterial plate began to aggregate instead of adhering to the surface [35] . Until now, several fabrication methods have been used to create spheroids (for review see Ref. [36] ) and include the hanging drop method [37] , microwells [15, 38] , and spinner flasks to enable spontaneous cell aggregation [39, 40] microfabricated devices [41] . These techniques provide 3D multicellular spheroids for high-throughput screening and the formation of complex, organotypic tissue grafts [42, 43] . Therefore, the combination of high throughput methods with spheroid culture and GFloaded MPs can lead to generation of highly reproducible hepatocytes in large numbers for biomedical applications (Fig. 9) .
Conclusion
In this study, we demonstrated that the delivery of GFs by incorporation of biodegradable MPs within hESC spheroids resulted in a cost-effective, efficient hepatocytic differentiation compared to the conventional method. The importance of this Fig. 9 . Schematic presentation shows the manufacturing process for mass production of hPSC-HLCs by GF-releasing MPs in a stirred suspension bioreactor. The incorporation of GF-loaded biodegradable polymeric MPs within human pluripotent stem cell (hPSC) spheroids in 3D suspension culture resulted in efficient hepatocyte differentiation. To have a cost-benefit application of GFs in large-scale differentiation in bioreactor, the total concentration of GFs was reduced to one-tenth by using MPs. hPSCs aggregated with GFloaded MPs through precipitation into multi wells of a micropatterned surface and generated high-throughput MP-incorporated 3D multicellular spheroids which subsequently provided large numbers of highly reproducible hepatocytic cells. This approach has provided a particularly attractive alternative for convectional supplementation of GFs for efficient and cost-effective scalable differentiation of suspension cultured hPSCs to HLCs. These HLCs have potential applications in drug discovery, disease model, bioartificial liver, tissue engineering, and regenerative medicine. method pertains to the delivery and availability of GFs over a constant time. The cost for hepatocytic differentiation of one million initial hESCs using the proposed MP-delivery was reduced by 6.60-fold in comparison with the convectional (soluble) approach (Supplementary Tables S3 and S4 ). Frozen vials that included a total of 10 Â 10 6 hPSCs could theoretically be thawed and, after 4 weeks, potentially produce up to 2 Â 10 9 hPSCs in four spinner flasks that contain a total of 400 mL of medium [2] . By our MP delivery approach, a clinically relevant cell number of hPSCHLCs (1 Â 10 9 ALB-positive cells) theoretically could be produced in the same flasks over a 3-week period [3] . Our approach prompted investigation of pairing small molecules and GFs, along with material interactions for more sophisticated spatiotemporal controlled delivery of GFs within hPSC spheroids. This approach could provide wide applications in drug discovery, bio-artificial liver devices, tissue engineering, and regenerative medicine.
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